Warning letter
Jamaica Hospital Medical Center IRB: warning letter of Feb 24, 2016
FDA warning letter 486430 · Center for Drug Evaluation and Research
Key facts
| Reference number | 486430 |
|---|---|
| Company | Jamaica Hospital Medical Center IRB |
| Subject | Institutional Review Board (IRB) |
| Issue date | Feb 24, 2016 |
| Posted date | Mar 8, 2016 |
| Issuing office | Center for Drug Evaluation and Research |
| Product type | Drugs |
| CFR sections cited | 56.115(a)(5), 56.115(a)(2) |
| Inspection city | Jamaica |
| Inspection ZIP | 11418 |
| Inspection start date | Aug 13, 2015 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: